Makers Laboratories Ltd Stock Price Today (NSE: MAKERSL)

Makers Laboratories Ltd

149.052.45 (1.62%)
Market Closed

Fundamental Score

...

Makers Laboratories Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Makers Laboratories Ltd share price today is 149.05, down 1.62% on NSE/BSE as of 31 July 2026. Makers Laboratories Ltd (MAKERSL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 88.06 (Cr). The 52-week high for MAKERSL share price is 186.70 and the 52-week low is 109.00. At a P/E ratio of 38.76x, MAKERSL is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 3.17% and a debt-to-equity ratio of 0.12.

Makers Laboratories Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
168.50
Low
144.25
Volume
2.6K
Change
+0.00%

Makers Laboratories Ltd share price chart: 0.00% return over the past month. 52-week high ₹186.70, 52-week low ₹109.00.

Makers Laboratories Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
150.00153.00149.05149.05170.00 (Cr)
155.00155.00146.20151.503.34K (Cr)
155.50156.50151.85152.301.77K (Cr)
153.00155.85148.10154.851.40K (Cr)
151.25154.80147.05151.702.35K (Cr)
148.00151.25148.00149.70348.00 (Cr)
155.00155.00153.60153.95281.00 (Cr)
149.75149.75149.75149.7510.00 (Cr)
153.65153.65149.05149.80805.00 (Cr)
148.25153.75148.25149.903.28K (Cr)

Makers Laboratories Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
148.80168.50144.25149.05+0.17%
163.30178.00138.00145.85-10.69%
140.35186.70140.35163.75+16.67%
130.65168.00130.65141.05+7.96%
142.90171.00133.60135.20-5.39%
128.00164.70116.05146.30+14.30%
123.45129.00112.10119.50-3.20%
125.00125.00109.00118.15-5.48%
122.00139.15117.15120.20-1.48%
130.00144.90119.00121.85-6.27%
147.60151.90128.50130.00-11.92%
152.00163.80144.50148.95-2.01%

Returns & Performance

Poor

Return on Equity (ROE)

3.17%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

9.28%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

7.89%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Makers Laboratories Ltd Valuation Check

Poor

Price to Earnings (P/E)

38.76x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.89x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

61.27%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.39%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

2825.00%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

5.46%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

15.43%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

49.27%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

49.27%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.12x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

13.88x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

3.94 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Makers Laboratories Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MAKERSL across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Robust Profit Growth (2825.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Consistent Growth Track Record (15.43% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (49.27% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (49.27% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.12)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (13.88x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (61.27%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Below-Average Return on Equity (3.17%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (9.28%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Limited Institutional Interest (FII+DII: 0.39%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Makers Laboratories Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Makers Laboratories Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
53.2/100
149
₹88.06
38.8
Average
3.17%
Poor
9.28%
Poor
0.1
Excellent
49.27%
Excellent
15.43%
Excellent
0.00%
66.4/100
1991
₹468821.49
37.7
Average
15.95%
Good
20.53%
Excellent
0.1
Excellent
16.75%
Excellent
11.78%
Good
0.82%
56.3/100
8056
₹193163.97
73.6
Average
16.53%
Good
21.96%
Excellent
0.0
Excellent
5.71%
Good
8.67%
Good
0.41%
51.4/100
5123
₹169902.02
77.5
Average
27.43%
Excellent
15.19%
Good
1.8
Average
12.07%
Good
11.80%
Good
0.76%
Cipla Ltd...
CIPLA500087
40.2/100
1473
₹116131.81
30.5
Average
11.60%
Average
15.49%
Good
0.0
Excellent
9.94%
Good
8.01%
Good
0.90%
74.1/100
1078
₹115375.77
21.3
Average
21.25%
Excellent
21.14%
Excellent
0.5
Excellent
18.77%
Excellent
12.45%
Good
0.09%
Lupin Ltd...
LUPIN500257
83.4/100
2415
₹113976.53
20.0
Average
28.68%
Excellent
29.93%
Excellent
0.3
Excellent
37.02%
Excellent
13.02%
Good
0.72%
61.5/100
2470
₹105053.91
52.3
Average
13.12%
Average
13.50%
Average
0.4
Excellent
10.52%
Good
18.10%
Excellent
0.04%
41/100
1148
₹102660.46
25.6
Average
11.22%
Average
13.04%
Average
0.2
Excellent
15.44%
Excellent
12.09%
Good
0.65%
24.6/100
1580
₹90035.87
25.4
Average
10.06%
Average
12.80%
Average
0.2
Excellent
0.80%
Average
6.32%
Good
0.26%
34.1/100
1816
₹84016.75
93.9
Average
18.30%
Good
17.76%
Good
0.5
Excellent
-1.89%
Poor
7.19%
Good
0.13%

Makers Laboratories Ltd Dividend History

Annual cash dividends paid by MAKERSL — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 20240.63 Cr
FY 20230.63 Cr
FY 20220.63 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Makers Laboratories Ltd Quarterly Performance

Latest quarterly metrics for MAKERSL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

5.46%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

2825.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

15.43%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

49.27%

Compounded annual net profit growth over 5 years

Makers Laboratories Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MAKERSL — calculated from daily price history

43RSI 14
Neutral — RSI 43

Momentum is balanced — neither overbought nor oversold.

SMA 50
153
▼ Price below SMA 50 — Short-term bearish
SMA 200
139
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
3K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Makers Laboratories Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Makers Laboratories Ltd (MAKERSL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Makers Laboratories Ltd

About MAKERSL (Makers Laboratories Ltd)

Makers Laboratories Ltd is a dynamic pharmaceutical entity deeply rooted in the Indian healthcare landscape, committed to developing, manufacturing, and distributing a diverse port...folio of pharmaceutical products. Operating with a dual focus, the company strategically divides its operations into two synergistic segments: pharmaceutical formulations and chemical manufacturing. This integrated approach enables Makers Laboratories to maintain stringent quality control throughout the entire production process, from the sourcing of raw materials to the final packaged product, ensuring patient safety and therapeutic efficacy. The company relentlessly pursues innovation, investing in research and development to create effective and affordable healthcare solutions tailored to the specific needs of the Indian population. The core of Makers Laboratories' success lies in its comprehensive range of therapeutic products, designed to address a broad spectrum of health concerns. The company offers solutions for common ailments and chronic conditions, including treatments for digestive disorders, infections, allergies, respiratory issues, and metabolic imbalances. Specifically, their product line features medications targeting acid reflux, parasitic worms, allergic reactions, asthma, bacterial infections, diabetes, diarrhea, nausea, fungal infections, hypertension, inflammation, pain, muscle spasms, malaria, and thyroid imbalances. This wide-ranging portfolio demonstrates Makers Laboratories' dedication to providing accessible and reliable healthcare solutions to meet the diverse medical needs of the Indian populace. Driven by a commitment to ethical business practices and unwavering quality standards, Makers Laboratories strives to enhance the well-being of individuals and communities. The company actively seeks to expand its reach and impact by leveraging its manufacturing capabilities, distribution networks, and strategic partnerships. With a strong emphasis on customer satisfaction and continuous improvement, Makers Laboratories remains dedicated to strengthening its position as a trusted provider of high-quality pharmaceutical products in the Indian market. They aspire to be a vital contributor to a healthier and more prosperous India.

Company Details

Symbol:MAKERSL
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Saahil U. Parikh
CEO and Executive Non-Independent & Whole Time Director
Mr. Nilesh Shivraj Jain
Senior Manager of Materials and Executive Non-Independent & Whole Time Director
Mr. Sandeep N. Kadam
Senior Manager of Accounts & CFO

MAKERSL Share Price: Frequently Asked Questions

What is the current share price of Makers Laboratories Ltd?

Makers Laboratories Ltd (MAKERSL) trades at ₹149.05 on NSE and BSE. Market cap ₹88.06 (Cr). Educational data only.

What is the P/E ratio of Makers Laboratories Ltd?

Makers Laboratories Ltd has a P/E of 38.76x vs industry average 34.89x.

What is the Bull Run score for Makers Laboratories Ltd?

Makers Laboratories Ltd has a Bull Run score of 53.2/100 based on 25+ financial parameters.

Does Makers Laboratories Ltd pay dividends?

Makers Laboratories Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Makers Laboratories Ltd?

Makers Laboratories Ltd has ROE of 3.17%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Makers Laboratories Ltd?

Makers Laboratories Ltd has debt-to-equity of 0.12.

Is Makers Laboratories Ltd a good investment?

Bull Run gives Makers Laboratories Ltd a score of 53.2/100. This is not investment advice — consult a SEBI-registered advisor.